PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
Total Valuation
PDS Biotechnology has a market cap or net worth of $43.56M. The enterprise value is $5.21B.
Market Cap$43.56M
Enterprise Value$5.21B
Share Statistics
PDS Biotechnology has 55,815,655 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,815,655
Owned by Insiders1.54%
Owned by Institutions5.96%
Financial Efficiency
PDS Biotechnology’s return on equity (ROE) is -3.98 and return on invested capital (ROIC) is -608.05%.
Return on Equity (ROE)-3.98
Return on Assets (ROA)-1.21
Return on Invested Capital (ROIC)-608.05%
Return on Capital Employed (ROCE)-1.50K
Revenue Per Employee0.00
Profits Per Employee-1.44B
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PDS Biotechnology is ―. PDS Biotechnology’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio3.86
Price to Fair Value3.86
Price to FCF>-0.01
Price to Operating Cash Flow<0.01
PEG Ratio0.03
Income Statement
In the last 12 months, PDS Biotechnology had revenue of 0.00 and earned -36.84M in profits. Earnings per share was -0.74.
Revenue0.00
Gross Profit0.00
Operating Income-31.54B
Pretax Income-35.67B
Net Income-36.84M
EBITDA-30.30M
Earnings Per Share (EPS)-0.74
Cash Flow
In the last 12 months, operating cash flow was 23.41B and capital expenditures 3.00, giving a free cash flow of 23.41B billion.
Operating Cash Flow23.41B
Free Cash Flow23.41B
Free Cash Flow per Share419.45
Dividends & Yields
PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.53
52-Week Price Change-16.58%
50-Day Moving Average0.69
200-Day Moving Average0.96
Relative Strength Index (RSI)63.29
Average Volume (3m)431.41K
Important Dates
PDS Biotechnology upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
PDS Biotechnology as a current ratio of 2.82, with Debt / Equity ratio of 56121.04%
Current Ratio2.82
Quick Ratio2.82
Debt to Market Cap145.02
Net Debt to EBITDA-170.45
Interest Coverage Ratio-5.91K
Taxes
In the past 12 months, PDS Biotechnology has paid -1.17M in taxes.
Income Tax-1.17M
Effective Tax Rate<0.01
Enterprise Valuation
PDS Biotechnology EV to EBITDA ratio is -171.63, with an EV/FCF ratio of -0.19.
EV to Sales0.00
EV to EBITDA-171.63
EV to Free Cash Flow-0.19
EV to Operating Cash Flow-0.19
Balance Sheet
PDS Biotechnology has $26.71M in cash and marketable securities with $5.19B in debt, giving a net cash position of -$5.17B billion.
Cash & Marketable Securities$26.71M
Total Debt$5.19B
Net Cash-$5.17B
Net Cash Per Share-$92.55
Tangible Book Value Per Share$0.20
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PDS Biotechnology is $9.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.75
Price Target Upside1150.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast29.95%